Paper692279
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
Jenner P and 4 others. Life Sci, 1978. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs. Papers, record 692279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/692279
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Behavior, Animal | Major topic |
| Benzamides | Major topic |
| Brain | Major topic |
| Haloperidol | Major topic |
| Receptors, Dopamine | Major topic |
| Adenylyl Cyclases | |
| Animals | |
| Female | |
| Homovanillic Acid | |
| Male | |
| Mice | |
| Rats |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7862816 | Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats. | Psychopharmacology (Berl) | 1993 | https://conductscience.org/library/papers/7862816 | PubMed |
| 7516074 | Palliative medicine. | Postgrad Med J | 1993 | https://conductscience.org/library/papers/7516074 | PubMed |
| 7155198 | Differential effects of sulpiride and metoclopramide on brain. Homovanillic acid levels and shuttle box avoidance after systemic and intracerebral administration. | Naunyn Schmiedebergs Arch Pharmacol | 1982 | https://conductscience.org/library/papers/7155198 | PubMed |
| 6798615 | Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6798615 | PubMed |
| 6345129 | Metoclopramide. An updated review of its pharmacological properties and clinical use. | Drugs | 1983 | https://conductscience.org/library/papers/6345129 | PubMed |
| 6162168 | Brain locations controlling the behavioral effects of chronic amphetamine intoxication. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6162168 | PubMed |
| 6141584 | Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6141584 | PubMed |
| 6119730 | Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6119730 | PubMed |
| 6112770 | Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6112770 | PubMed |
| 4084483 | Stimulation of dopamine receptors (type 2) lowers human intraocular pressure. | Br J Ophthalmol | 1985 | https://conductscience.org/library/papers/4084483 | PubMed |
| 3128811 | The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3128811 | PubMed |
| 3088638 | BRL 20596, a novel anilide with central dopamine antagonist activity. | Psychopharmacology (Berl) | 1986 | https://conductscience.org/library/papers/3088638 | PubMed |
| 2957718 | Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/2957718 | PubMed |
| 2895483 | Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/2895483 | PubMed |
| 2568655 | Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2568655 | PubMed |
| 1678894 | Effects of cannabidiol in animal models predictive of antipsychotic activity. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/1678894 | PubMed |
| 44375 | Sulpiride in tardive dyskinesia. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/44375 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/692279
GET https://conductscience.org/api/papers/v1/692279/authors